Covance aquires antibodies product line of Sternberger Monoclonals
Covance Inc. announced that its wholly owned subsidiary, Covance Research Products Inc., has acquired the complete line of antibodies developed by Sternberger Monoclonals Inc. (SMI), of Lutherville, MD. These products are ideally suited for immunohistochemical studies and complement Covance's extensive suite of antibody products for neuroscience and neurodegenerative disease research and discovery.
As a subsidiary of one of the world's largest and most comprehensive drug development services companies, Covance Research Products is uniquely positioned to support the Sternberger antibodies suite. The company supports biomedical scientists with a select catalog of antibody products, including leading products in the areas of neuroscience, epitope tags, and cell biology. In addition, for the last several years, Covance has produced the Sternberger antibodies under contract for SMI.
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous